Genomics

    The rapid development of COVID vaccines was made possible by genomics, the science of genetic sequencing. The leading tech company behind the gene decoding equipment is Illumina, which produced its first commercial genome in 2006 at a cost of $150,000. Today, it can sequence a human genome in an hour for $600 and they expect to get that down to $100 in the near future. This is not only good news for treating infectious diseases. Cancer researchers and others are benefiting as well. The more accessible genomics becomes, the better chance we have of achieving inclusive healthcare for all.

    — Wayne Visser

    More on Technology & Innovation

    From Purpose Inspired: Reflections on Conscious Living, Volume 5. Buy on Lulu ↗